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Objective- This study aims to identify the microorganisms 
and antibiotic resistance patterns in necrotising fasciitis. 
Methods- This is a retrospective audit over two consecutive 
years (June 2015 - July 2017) of all patients who had surgery for 
necrotising fasciitis at an ACS unit. 
Results- Necrotising fasciitis accounted for 15% of all skin and 
soft tissue sepsis that required surgery. There were 10 male 
(52.6%) and nine female (47.4%) patients. The most common 
co-morbidity was diabetes mellitus in 10 (52.6%) patients, the 
compliance and control were monitored by glycosylated 
haemoglobin (HbA1C) in 50% of the diabetic group, with a mean 
of 8.98 (Range 5-12.9). Fifteen percent of cases (n=3) had a 
confirmed diagnosis of HIV, with a negative result in eight (42%). 
ICU was required in three patients two of whom were on 
inotropes and one patient required renal replacement therapy. 
Surgery was performed within 24 hours for 11 (57%) patients. 
The most common anatomical site for debridement was 
perineum in nine patients (47%). Monomicrobial infection was 
the most common subtype of necrotising fasciitis with methicillin 
sensitive staphylococcus aureus in five (26%) as the 
predominant microbe. Gram-negative organism Escherichia-coli 
was the second most common monomicrobial infection. All 
Gram-positive organisms were sensitive to cloxacillin and co- 
amoxiclavulanic acid. Two gram negatives(15%) of the 13 
organisms cultured were resistant to co-amoxiclavulanic acid. 
The 30 day mortality was 15%. 
Conclusion- Necrotising fasciitis is a rare but lethal infection. In 
our limited series, monomicrobial infection is the most common 
subtype. 15% of the community acquired organisms were 
resistant to the empiric antibiotic of choice co-amoxiclavulanic 
acid. (word count= 261) 
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A literature search for necrotising fasciitis using medical search 
databases such as PubMed and Google scholar was used. The primary 
focus was the contemporary microbiology and management. The 
historical relevance development of diagnostic strategies was 




Necrotizing soft-tissue infections (NSTIs) are life-threatening, 
invasive often rapidly spreading soft-tissue infections which can 
involve any or all layers of the skin and soft-tissue compartment. 
It primarily involves the relatively avascular muscle fascia and 
can later cause secondary necrosis of surrounding 
subcutaneous fat and skin. Classically the appearance of tissue 
has been described by the friability of the tissue and loss of 
tissue planes which is associated with dish-water grey exudate 
with or without purulent collections.1 The pathophysiology of 
necrotising fasciitis (NF) involves a breach of the skin barrier 
protection or by haematogenous spread of the bacterium.1 
Immune suppression due to various chronic ailments e.g. 
diabetes mellitus has been associated with an increased 
predisposition for NF. The incidence of NSTI in the western 
countries has been described as 0.4 per 100 000 population and 
associated with mortality ranging from 30-80% depending on the 
subtype and immune status of the patient.2 In South Africa, we 
do not know the incidence or mortality of necrotising fasciitis. The 
underlying socioeconomics of a middle to low income country 
results in delayed access to health care, delayed diagnosis and 
delay to surgery. Immune suppression from poorly controlled 
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diabetes or untreated HIV could impact outcomes. There is no 
data to support or refute these clinical impressions. There are 





BL Wilson in 1952 first coined the name necrotising fasciitis in 
his article.3 These were a case series of overt clinical signs of NF 
with necrosis spreading to skin and muscle. Since then various 
terms have been used to describe this entity such as ‘Flesh 
eating bacterial infection’, ‘Haemolytic streptococcal gangrene’, 
‘Gas gangrene’, ‘Wet gangrene’ and ‘Fournier’s gangrene’ if it 
involves the perineum. The currently acceptable nomenclature is 
‘Necrotising soft tissue infection’ (NSTI) which is an umbrella 
term that encompasses necrotising cellulitis, fasciitis and 
myositis. The NF variety is the most lethal due to its ability to 
progress rapidly and sometimes the necrotic skin and muscle are 




NF is a rare surgical clinical entity. The historic heterogeneity of 
the nomenclature for NSTI’s results in difficulty in calculating its 
true incidence. In the United Kingdom, the incidence is estimated 
at 0.24-0.4 per 100 000 adults.4 Similarly in the United States of 
America based on a 13 year retrospective review the incidence 
of NF was estimated at 3 800 - 5 800 admissions per year.5 The 
incidence of NSTI due to invasive group A streptococcal (GAS) 
infections in the United States is 0.4 per 100,000, according to 
active surveillance data from the Center of Disease Control 
(CDC).6 
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The incidence of NF in Thailand is reported as 15.5 per 100 000 
and was associated with high rates of limb loss or amputation.7 
The figures for many African countries and other middle to low 
income countries are lacking including for South Africa. The 
increasing worldwide obesity and hence diabetes mellitus rates 
could result in an increased incidence of NF. There was a 35% 
cumulative increase between 2001 and 2010 with a 2.7% per 
year increase in a study from Texas.8 This is the largest cohort 
study on NF epidemiology trends in the literature. There are 
small case series over a period of time suggesting a global 





Inoculation may be direct via trauma (sometimes minor) or 
surgery i.e. insect bites, lacerations, surgical incisions, illicit drug 
use and child-birth, or could be indirect where local inflammation 
facilitates the haematogenous entry of exotoxins.1,5,10 
These bacteria then release toxins which stir an inflammatory 
response and cause thrombosis in the venules and arterioles 
which leads to ischaemic necrosis of skin, subcutaneous and 
muscular layers.11 The bacteria release enzymes which enable it 
to liquefy barriers and promote the spread of infection.12 There is 
a balance of host factors (genetic factors which regulate the pro-
inflammatory cytokines) and micro-organism virulence (which 
stimulate the severity of the inflammatory response). It is this 
overwhelming inflammation that leads to local tissue destruction 
and systemic multi-organ involvement. There is a vicious cycle 
of fulminant infection, toxin production, cytokine activation, 
micro- thrombosis and ischemia, and tissue dysfunction and 
death, which progresses rapidly unlike in uncomplicated non- 
necrotizing skin and soft tissue infections. The toxin-producing 
organisms like Staphylococcus aureus can lead to toxic shock 
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syndrome. These exotoxins cause diffuse vasodilatation, affect 
cardiac contractility, increase the permeability of capillaries etc. 
Patients have multi-organ failure due to the diffuse action of 




NF can be classified according to its microbiology, anatomical 
area and depth of necrosis. However the preferred classification 
uses microbiology and was first reported by Giuliano et al in 
1977.14 He described the microbiology of NF into two distinct 
entities, type I polymicrobial and type II monomicrobial.14 Based 
on the classification created by Giuliano et al modified the 
classification in 1998 with the addition of the third subtype.15 
Finally, the fourth subtype was added by the pathologist Jain et 
al in India in 2006 to complete the modern classification as it is 
known today.16 
This expands to include two extra subtypes onto the previous 
classification, and is currently the preferred one to use.4 
 
Modified Guiliano classification 
 
 
Types of NF Aetiology Organisms 
Type 1 Polymicrobial/synergistic 
often bowel flora-derived 
Type 2 Often monomicrobial, skin 
or throat derived 
 
Type 3 Gram-negative often 
marine related organisms 
Mixed anaerobes and aerobes 
 
Usually group A  - haemolytic 
streptococcus (GAS) 
occasionally ± staphylococcus aureus 
Vibrio species mainly 
Type 4 
(fungal) 











In this classification Type, I is polymicrobial, the major cause (70- 
80%) of NF in clinical practice. The bacterial mixture is 
anaerobic, aerobic and facultative anaerobic bacteria. It usually 
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has three or more bacteria involved that work synergistically. It 
affects the immunocompromised and is easier to recognise and 
has a better prognosis when compared with the other subtypes. 
The mortality rate of Type I necrotising fasciitis is variable and 
depends on the immune status of the patient. Common causes 
of Type I NF are perianal sepsis, intra-abdominal sepsis and 
post-surgery necrotising fasciitis. 
 
Type II is monomicrobial gram-positive sepsis which is usually 
Group A streptococcal or staphylococcus aureus infection from 
skin or throat infection. It is the second most common subtype 
and has been associated with 20-30% of infections. Presentation 
may initially seem innocuous however if not treated adequately 
is very aggressive and may be associated with toxic shock 
syndrome. The mortality of Type II is more than 32% and 
increases if associated with myositis and with toxic shock 
syndrome (TSS) is 23-44%. Immune suppression is not 
necessary and infection can be sporadic in nature.4,13 
 
Type III is usually monomicrobial with a gram-negative organism, 
often marine (Vibrio and Aeromonas species) but not confined to 
it. It has been commonly described in Asia following ingestion of 
contaminated seafood or wounds being infected by 
contaminated water. Non-marine gram-negative infection is not 
very common and involves the Haemophilus influenzae, 
Klebsiella species or Aeromonas species (freshwater). Within 
this category, the digestive enzymes associated with marine 
subtype tend to increase its mortality rate (30-40%) when 
compared with the other gram-negative.4,17 
 
Type IV NF caused by fungal sepsis which is related to traumatic 
jury i.e. burn injury and polytrauma patients with prolonged 
hospitalization or in transplant patients on immunosuppresion. 
candida is mostly associated with infection 
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in the immunocompromised population whereas mucor or 
rhizopus species are related to immune competent patients. Due 




The classification by Sarani et al combines microbiology with 










Fournier’s gangrene of perineum/ scrotum 
Depth of infection Necrotising adipositis (most common) 
fasciitis, myositis 
 
Microbial cause Type I: Polymicrobial (most common) 
 
Type II: Monomicrobial Staphylococcus, 
Streptococcus, Clostridia Species 
 







The most common predisposing medical condition in patients 
with NF is diabetes mellitus with its impaired cutaneous wound 
healing and increased susceptibility to infection. These patients 
tend to have higher risks of amputation when compared to non- 
diabetics for limb NF.19 However, other conditions which may 
predispose to a decreased immune status also contribute to 
susceptibility i.e. HIV infection, end-stage kidney disease, post-
transplantation on immune suppressive drugs, other cancer 
types and liver cirrhosis.20,21 
 
The other known risk factors contributing to the development of 
NF are intravenous drug use, peripheral vascular disease and 
increased age, particularly above 50 years have been related to 
high morbidity.2,4,22 Neglected pressure sores or peri-anal sepsis 
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increases the risk of development of NF. Delay not only worsens 
the clinical presentation but negatively affects the clinical 
outcome if a large area is debrided. 
 
In a Taiwanese hospital, Cheng et al noted that there are clinical 
parameters that are associated with higher mortality in diabetic 
and non-diabetic alike; these are related to admission 
hypotension and dyspnoea. Other features include the 
thrombocytopenia, hyperkalaemia and a positive blood culture. 
Diabetics though were more likely to have an amputation related 
to the treatment of NF.19 
 
Although HIV related immunosuppression is a risk factor for 
perineal or anorectal infections and NF, it does not seem to have 
a worse prognosis. In literature describing the presentation of 
Fournier’s gangrene in sub-Saharan countries, Meki et al found 
that the HIV infection was not statistically significant risk factor 
for mortality. Rather they also concluded that the body surface 
area that required debridement was far more significant.23,24 
 
Even though the rates of new HIV infection have increased in the 
USA and South Africa alike; the access to antiretroviral 
medication has ensured that HIV can be treated like any chronic 
comorbidity. There is evidence that CD4 count below 200 
cells/mm3 and a viral load above 30 000 copies/ml have been 
associated with an increase with infectious complications and 
mortality.25 The decrease in CD4 lymphocytes results in 
decreased wound strength.26 
 
When Sandler et al investigated the outcomes of HIV/AIDS 
patients who have emergency surgery they concluded that in the 
emergency setting unless the patient had an AIDS defining 
disease the presence of HIV infection did not significantly affect 
the mortality or morbidity. However, if the patient did not have 
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viral suppression then poorer outcomes were to be expected in 
those patients.25 These poor outcomes were the common post-
surgical complications i.e. pneumonia, thromboembolism, 
wound complications, urogenital sepsis and myocardial 
infarctions. The proportion of morbidity and mortality was 
significantly higher in patients who had AIDS compared to well 




Predictors of poor outcome 
 
There are many factors reported by Kalaivani et al that are 
associated with a poor outcome. These are advanced age 
(particularly above 50 years), raised creatinine at the time of 
admission and delay of debridement by 24 hours.20 In this series, 
the authors also noted a higher morbidity when a larger surface 
area is debrided. Lastly, it was noted that even though diabetic 
related infection is the most common co-morbidity, its presence 





The spectrum of clinical picture is wide, depending on the 
progression of necrosis. Initially, it can present like cellulitis 
(erythema, soft tissue swelling) and can be a diagnostic 
dilemma. Necrotising fasciitis tends to be tenser and extremely 
painful. This pain can be masked if patients have received anti-
inflammatory medication. A clinical picture suggestive of 
‘cellulitis’ with signs of systemic toxicity should alert the clinician 
to a potential diagnosis of NF. As necrosis progresses this might 
be more obvious with haemorrhagic bullae, anaesthesia, skin 
necrosis. These are late signs. Crepitus in the tissue is present 
with organisms that produce 
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hydrogen or nitrogen. Clostridium perfringens is the most 
commonly associated bacteria with crepitus. Signs of systemic 
toxicity include tachycardia, tachypnoea, arrhythmias, shock, 
metabolic acidosis, hypoxia and multi organ failure. Diagnosis 
usually requires a high index of suspicion. With established 





Late presentation of NF is usually an obvious diagnosis. The 
diagnostic dilemma question arises when the symptoms are 
early, this is when radiological assistance is necessary and can 
hasten surgical intervention. There are four imaging modalities 
each with advantages and disadvantages that allow for their use 
in the emergency setting. Plain x-rays which are readily 
available, show swelling of the soft tissue and the presence of 
gas in the subcutaneous which indicates gas forming organisms. 
The localisation of a foreign body as a source of infection can be 
confirmed on plain x-rays. However, it is unable to estimate the 
extent of tissue involvement.27 
 
The use of ultrasound is operator dependant even though it is 
readily available, it may underestimate the extent of disease.27 
The typical features seen are an increase in the distortion of 
fascial layers, hypervascularity, or increased thickness of the 
subcutaneous tissue.27 With the presence of soft tissue gas this 
may indicate abscess collection or necrosis. 
Contrasted computed tomography (CT) features that are 
diagnostic of NF fascial air tracking, muscle oedema, fluid 
collections in fascial spaces that more than expected with 
oedema, subcutaneous oedema, lymphadenopathy and regional 
vasculature thrombosis.28–30 The common side effects 
associated with this type of radiology is contrast associated 
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allergy and renal failure especially in diabetic or chronic renal 
failure patients. 27,31 
 
Magnetic resonance imaging (MRI) is the best modality for 
diagnosing soft tissue infections. Gadolinium based contrast 
medium is used therefore an anaphylactic reaction can be 
prompted however this is infrequent when compared to CT. 
Signs suggestive of NF are there is increased signaling on fluid 
sensitive sequences extending along deep thickened fascial 
planes. Fat suppressed T2 weighted images show varying 
inflammatory changes. Due to hypoperfusion the extent of 
disease evidenced by contrast enhancement may be 
underestimated. Gas in the deep fascial planes is not seen 
consistently on MRI as on CT. Nevertheless, the signal voids 
seen on gradient echo sequence is pathognomonic of NF.27 
 
There can be doubt in the very early diagnosis of NF and a quick 
bedside test of making an incision on the affected area down to 
the fascia to confirm necrosis or even send a specimen for a 
frozen section.32 This modality could be of some assistance 






The Laboratory Risk Indicator for Necrotising Fasciitis(LRINEC) 
was developed by Wong et al, to aid in distinguishing the more 
lethal yet early NF from severe soft tissue infection. It uses 
biochemical parameters of C-reactive protein (CRP), white cell 
count, glucose, creatinine, haemoglobin and sodium, which are 
scored to a total of 13 points to calculate a probability score. 
These are used to categorise patients into a low, medium or high 
probability of their presentation being necrotising fasciitis.33 
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This study was a retrospective observational analysis of patients 
who presented with NF. The primary outcome was to 
differentiate early NF from complicated soft tissue infection.33 
Many investigators have tried to utilise the scoring system to 
acquire similar results to the initial LRINEC score, however, this 
has not proven to be possible. The negative - (94%) and positive 
predictor values (92%) have not been reproducible for LRINEC 
scores more than six in other studies though. CRP has been 
thought to be a routine investigation in working up patients. 
Unfortunately, many retrospective studies have not been able to 
completely adhere to the score because of its data 
inconsistencies.34,35 Knowing that malignancy is a risk factor for 
developing NF, Foo et al showed that in haematological 
malignancy LRINEC was not a reliable score, 75% of patients 
who clinically were treated for NF had a score below six.34,36 
They postulate that this subset of patients has a low white cell 
count, thrombocytopenia and anaemia all of which are 
necessary for the calculation. 
Even though it has not been fully validated, it continues to be 
presented in the management algorithms of NF as a useful 
adjunct to increase suspicion in severe or complex soft tissue 
infections.34 Prospective studies specific to the utility of the 
LRINEC score are needed to validate its use in clinical practice 
or if the score needs to be amended to include some clinical 
parameters too. While the LRINEC score has been utilized to 
diagnose early NF, Menyar et al has shown that patients 
presenting with an LRINEC score above six are associated with 
an increase in septic shock, prolonged ICU admission and 
mortality37. Similarly, Su et al concurs that higher LRINEC scores 
are associated with sicker patients who are at higher risk for 
mortality and limb loss.38 
 
Unlike the LRINEC score, the Fournier’s’ gangrene severity 
score (FGSI) introduced by Laor et al in 1995 includes clinical 
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parameters to determine the prognosis and survival.39,40 These 
are clinically temperature, heart rate and respiratory rate 
alongside biochemical markers i.e. sodium, potassium, 
haematocrit, white cell count and bicarbonate. A score above 
nine indicates a 75% probability of death and thus those with a 
score below nine are associated with a 78% probability of 
survival. Currently, the studies that have been used to validate 
the use of FGSI have been retrospective and of those, the largest 
is reported by Corcoran et al who reported on their 10 year 
experience.41 They did however agree that the limitation of their 
study was its retrospective nature and concluded that there 
needs to be a prospective evaluation to improve the quality of 
evidence for the use of the FGSI score. 
 
A prediction of death score has been created by Anaya et al 
using the following variables: Minor - HR more than 110; 
temperature less than 36°C; serum creatinine 132µmol/L and 
Major - WCC >40, age >50years and Hct >50%. The total points 
for the score were 12, with the probability of mortality being 6% 
if less than two points and 88% if there were more than six 
points.42 This is a retrospective analysis from which patients can 
be stratified to ones who need more intensive care (ICU) and 
those who may not require intensive intervention. Prospective 




The antibiotic guidelines vary from country to country. Empiric 
therapy needs to have broad coverage to include gram-positive, 
gram-negative and anaerobic organisms. Both the British and 
American antibiotic guidelines recommend the use of anti- 
methicillin-resistant staphylococcus (MRSA) (daptomycin or 
vancomycin) and broad-spectrum gram-negative cover 
(piperacillin-tazobactam, extended-spectrum cephalosporins or 
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carbapenems) and anaerobic coverage (metronidazole or 
clindamycin). Antifungal cover (fluconazole) should be added if 
there is microbiological confirmation of fungal sepsis.17 
Gentamycin is added to the prescription chart in the British 
guidelines whenever the source of sepsis is intra-abdominal, 
pelvic or perineum. This is based on local resistance patterns. A 
multi-institutional study performed in the USA by Kao et al 
showed that in the cultured specimens the majority gram-positive 
organisms were MRSA (35%) compared to sensitive 
staphylococcus (16%) or streptococcus only in 15%. Also noted 
in that series was the low number of gram-negative (10%), 
anaerobes (5%) and fungi (4%) cultured.43 In a retrospective 
review done by Das et al in New Zealand showed that gram-
positive organisms were more common in patients diagnosed 
with NF over a 6-year period.44 Of the gram-positive organisms, 
the streptococcus species (41%) were the most common 
followed by staphylococcus species (31%). The methicillin-
resistant staphylococcus (MRSA) accounted for 3.1% of NF 
cases, gram-negative bacilli accounted for less than 10% and 
anaerobes were less than five percent. 
Perineal NF is commonly caused by commensal organisms of 
the rectum, vagina and urethra. Bjurlin et al showed in a 
retrospective series that the majority (83%) of their cultured 
specimens were polymicrobial. In descending frequency 
Bacteroides, E-coli, Streptococcal and methicillin sensitive 
Staphylococcus were cultured. However, monomicrobial sepsis 
showed a dominance of staphylococcus infection (28%) with 
MRSA accounting for 14% of the total infections.45 This group 
also noted that candida infections (7%) particularly in diabetic 
patients are increasing as well as community acquired MRSA.45 
Group A streptococcal infection of the soft tissue is sensitive to 
beta lactam antibiotic and evidence shows that when given to 
mice in combination with lincosamide (clindamycin) the microbial 
numbers are decreased significantly despite a delay in initiation 
of 
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therapy.46 Stevens et al explain that the penicillin’s mechanism 
of action is based on binding the penicillin binding proteins (PBP) 
which are expressed on the wall of the organism. The number of 
these PBP are varied based on the growth phases and are 
significantly reduced during the stationary phase which 
decreases the efficacy of beta lactam organism. Therefore, the 
addition of lincosamide can suppress toxin synthesis, decrease 
the PBP’s which decrease the integrity of the organism wall and 
has a longer post antibiotic effect.13,46 
 
In South Africa empiric therapy includes co-amoxiclavulanic acid 
until clinical resolution of symptoms following surgical 
debridement. However, if it is not available then ampicillin, 
gentamycin and metronidazole should be given. In case of 
refractory of penicillin allergy the antibiotic cover should include 
clindamycin and ciprofloxacillin.47 Unlike the first world countries 
the methicillin resistant staphylococcus is not covered in the 







De-escalation of antibiotic therapy is determined by obtaining 
adequate specimens that can be evaluated for microbiology. 
Ensuring the microbiologist receives adequate specimens aid in 
the clinical management of the patients. Therefore, it is 
imperative that the surgeon samples correctly. When 
fluid/aspirate is collected the volume must be adequate and not 
mixed with any other media. The site needs to be sterile (aseptic 
technique) and the ideal site is the deep portion of an infected 
area so as not to confuse the tissue with contamination of 
samples. Tissue size is to be approximately 3-4mm3 for delivery 
of similar strips of tissue for various media.48 Collection of swabs 
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of the tissue are not adequate samples as they do not have 
appropriate volumes required for inoculation into the different 
media. Similarly, the swab strands trap the fluid and do not allow 
for proper microbiology identification. 
 
 
Surgery and timing 
 
The cornerstone of NF management is surgical debridement. 
The fascial necrosis and sepsis are poorly perfused and hence 
antibiotic penetration alone is not adequate. The necrotic tissue 
allows bacterial growth and perpetuates the vicious cycle of 
spreading sepsis. The purpose of debridement is to remove 
necrotic tissue, collect adequate tissue specimen for culture and 
sensitivity and allow adequate assessment of surface area or 
depth of sepsis with deep compartment involvement that might 
require limb ablation.1 All necrotic and inflamed tissue should be 
removed to include the fascial layer. Tunnelled debridement 
should be avoided. Although the skin and subcutaneous tissue 
above necrotic fascia might still look viable, it is only a matter of 
time before it also becomes necrotic as the perforator vessels 
are involved in sepsis and thrombosis. This also doesn’t allow to 
fully ensure a healthy margin is reached as the direct vision of 
fascia is impaired. The “finger test” where the finger can easily 
able to traverse tissue planes can be used as a guide on how far 
the debridement should go. A margin of bleeding healthy tissue 
should be left behind.4,11 The surface area that is debrided 
should not be considered while there is still unhealthy tissue 
involved as it has already been shown to associated with poor 
outcomes if there is inadequate debridement. 
Literature confirms that complete adequate debridement is 
imperative to decrease morbidity and mortality.32,49 Ideally early 
debridement (less than 12 hours) is associated with lower 
mortality and morbidity. Notably, delay (more than 24 
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hours) may result from severe hypotension and the need for 
resuscitation. The septic shock process could is the reason for 
their overall poor outcome.50 Kobayashi et al showed in a 
retrospective study of early debridement that patients who 
underwent delayed debridement have an increased risk of 
multiple relook debridements and acute renal injury. Thus, the 
World Society of Emergency Surgery (WSES) consensus 
meeting in 2018 recommends that early debridement for NF 
should be sought.11 Following initial debridement, the wound 
ought to be inspected daily until confirmation of no sepsis and 
treated surgically when required.1 
Closure of soft tissue defect should be done soon after an 
infection has been excluded, a simple split skin graft on a 
granulated bed suffices. Granulation tissue can be encouraged 
by the use of negative pressure dressing. However, more 
complex tissue closures are to be planned for if there is extensive 





Hyperbaric oxygen (HBOT) continues to be recommended as an 
adjunct to therapy for NF. The delivery of 100% oxygen directly 
to the wound bed allows for a high tissue concentration. This 
improves leukocyte function, inhibition of anaerobic growth, 
inhibition of toxin formation and enhancement of antibiotic 
therapy.11,51 Protocols on the administration of the oxygen vary. 
Cocanour et al recommend 2.3 atmospheres given 2-3 sessions 
daily each lasting 30-90 minutes until healing occurs.51 A high 
incidence of seizures due to oxygen toxicity is a potential side 
effect, thus patients should be monitored closely. Another side 
effect is baro-pressure particularly in the middle ear which should 
be managed prophylactically via decompression. Though 
potentially useful its use in standardized protocols remains 
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controversial, studies are ongoing related to the various uses of 
HBOT. 
 
Intravenous immunoglobulin G (IVIG) has been mentioned as an 
adjunct in the management for NF. The rationale for use is its 
ability to neutralize extracellular toxins that mediate 
pathogenesis. Primarily investigated in group A streptococcal 
infection which is very severe and is known to be caused by toxin 
producing bacteria. A double blind randomized trial was 
terminated early due to slow patient recruitment which was 
meant to investigate the efficacy in GAS infection.52 The interim 
results suggest though that there was decreased renal failure 
and neutrality of super-antigens in the group treated with IVIG. 
Recently another double-blind placebo-controlled trial compared 
placebo to IVIG according to self-reporting patients on 
functionality. IVIG or normal saline was given over three days for 
the patients admitted in ICU along with clindamycin (which also 
lowers virulence of bacterial antigens). No significant difference 
was noted in post admission performance or ICU related 
complications.53 Therefore, the use of IVIG still has not been 
proven to add benefit in the NF, and thus not included in most 
treatment algorithms. 
 
Reltecimod (AB103) is a biologic agent which is now being 
investigated for use in the aftermath of an infection. It works by 
being a CD28 mimetic and inhibits the binding of the 
superantigen to the T helper cell receptor. Since this 
experimental drug has shown efficacy in animal models it was 
tested for safety in human subjects and showed that there were 
no lethal adverse effects. Secondly, the higher dose 
administration of the drug was related to lower organ failure post 
day seven in ICU compared to placebo. Further investigation is 
necessary to then prove efficacy as related to NF at the higher 
dose that was given in the pilot study.54 
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NF is a lethal disease with a high morbidity and mortality rate. 
Being able to recognize the risk factors allows for the index of 
suspicion to increase thus management is initiated earlier. 
Notably when the microbiology is known the antibiotic 




1. Stevens DL, Bryant AE. Necrotizing soft-tissue infections. 
N Engl J Med. 2017;377(23):2253–65. 
2. Lancerotto L, Tocco I, Salmaso R, Vindigni V, Bassetto F. 
Necrotizing fasciitis: Classification, diagnosis, and 
management. J Trauma Acute Care Surg. 
2012;72(3):560–6. 
3. Wilson B. Necrotising fasciitis. Am J Surg. 1952;(18):416– 
31. 
4. Morgan MS. Diagnosis and management of necrotising 
fasciitis: A multiparametric approach. J Hosp Infect. 
2010;75(4):249–57. 
5. Psoinos CM, Flahive JM, Shaw JJ, Li Y, Ng SC, Tseng JF, 
et al. Contemporary trends in necrotizing soft-tissue 
infections in the United States. Surg (United States). 
2013;153(6):819–27. 
6. Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren M 
Lou, Lynfield R, et al. Epidemiology of invasive group a 
streptococcal infections in the United States, 2005-2012. 
Clin Infect Dis. 2016 Aug 15;63(4):478–86. 
7. Khamnuan P, Chongruksut W, Jearwattanakanok K, 
Patumanond J, Tantraworasin A. Necrotizing fasciitis: 
epidemiology and clinical predictors for amputation. Int J 
Gen Med. 2015;8:195–202. 
8. Oud L, Watkins P. Contemporary trends of the 
epidemiology, clinical characteristics, and resource 
utilization of necrotizing fasciitis in Texas: A population- 
based cohort study. Crit Care Res Pract. 2015;2015. 
9. Sun X, Xie T. Management of Necrotizing Fasciitis and Its 
Surgical Aspects. Vol. 14, International Journal of Lower 
25  
Extremity Wounds. 2015. p. 328–34. 
 
10. Azar T, McHenry CR, Ramahi AJ, Collins PL. Pregnancy 
Complicating and Puerperium. 7844(5):823–6. 
11. Sartelli M, Guirao X, Hardcastle TC, Kluger Y, 
Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E 
consensus conference: Recommendations for the 
management of skin and soft-tissue infections. World J 
Emerg Surg. 2018;13(1):1–24. 
12. Cree IC. Necrotizing Fasciitis: A deadly disease. East Cent 
African J Surg. 2005;10(2):113–9. 
13. Lappin E, Ferguson AJ. Gram-positive toxic shock 
syndromes. Lancet Infect Dis. 2009;9(5):281–90. 
14. Giuliano A, Lewis F, Hadley K, Blaisdell FW. Bacteriology 
of necrotizing fasciitis. Am J Surg. 1977;134(1):52–7. 
15. Low DE, McGeer A. Skin and soft tissue infection: 
Necrotizing fasciitis. Curr Opin Infect Dis. 1998;11(2):119– 
23. 
16. Jain D, Kumar Y, Vasishta RK, Rajesh L, Pattari SK, 
Chakrabarti A. Zygomycotic necrotizing fasciitis in 
immunocompetent patients: A series of 18 cases. Mod 
Pathol. 2006;19(9):1221–6. 
17. Bonne SL, Kadri SS. Evaluation and Management of 
Necrotizing Soft Tissue Infections. Infect Dis Clin North 
Am. 2017 Sep;31(3):497–511. 
18. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing 
Fasciitis: Current Concepts and Review of the Literature. 
Vol. 208, Journal of the American College of Surgeons. 2009. p. 
279–88. 
19. Cheng NC, Tai HC, Chang SC, Chang CH, Lai HS. 
Necrotizing fasciitis in patients with diabetes mellitus: 
26  
Clinical characteristics and risk factors for mortality. BMC 
Infect Dis. 2015;15(1):1–9. 
20. Kalaivani V, Hiremath B V., Indumathi VA. Necrotising Soft 
Tissue Infection-risk factors for mortality. J Clin Diagnostic 
Res. 2013;7(8):1622–65. 
21. Leiblein M, Marzi I, Sander AL, Barker JH, Ebert F, Frank 
J. Necrotizing fasciitis: treatment concepts and clinical 
results. Eur J Trauma Emerg Surg. 2018 Apr 8;44(2):279– 
90. 
22. O Brien K, Bernard B BL et al. Epidemiology of invasive 
group A streptococcus in the United States, 1995-1999. 
Pediatr Infect Dis J. 2003 Nov;22(11):1031. 
23. Meki CS, Mangwiro TI, Lazarus J. Fournier’s gangrene: 
Outcome analysis and prognostic factors. South African J 
Surg. 2018;56(3):43–6. 
24. Elsaket AE, Maharajh S, Urry RJ. The presentation, 
management and outcomes of Fournier’s gangrene at a 
Tertiary urology referral centre in South Africa. South 
African Med J. 2018;108(8):671–6. 
25. Sandler BJ, Davis KA, Schuster KM. Symptomatic human 
immunodeficiency virus-infected patients have poorer 
outcomes following emergency general surgery: A study 
of the nationwide inpatient sample. J Trauma Acute Care 
Surg. 2019;86(3):479–88. 
26. Baum CL, Arpey CJ. Normal Cutaneous Wound Healing: 
Clinical Correlation with Cellular and Molecular Events. 
2005;(31):674–86. 
27. Turecki MB, Taljanovic MS, Stubbs AY, Graham AR, 
Holden DA, Hunter TB, et al. Imaging of musculoskeletal 
soft tissue infections. Skeletal Radiol. 2010;39(10):957– 
71. 
27  
28. Matsuura H, Iwasa K. Fournier gangrene. Cleve Clin J 
Med. 2018;85(9):664–5. 
29. Becker M, Zbären P HR et al. Role Fasciitis in Diagnosis 
ofthe Management ’ Neck : Radiology. 1997;(202):471–6. 
30. Fugitt JB, Puckett ML, Quigley MM, Kerr SM. Necrotizing 
fasciitis. Radiographics. 2004;24(5):1472–6. 
31. Chaudhry, Ammar, Gul M. Imaging characterisits of soft 
tissue infections: Part 1. Contemp Diagnostic Radiol. 
2015;36(15):1–5. 
32. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, 
Kanavidis P, Machairas A. Current Concepts in the 
Management of Necrotizing Fasciitis. Front Surg. 
2014;1(September):1–10. 
33. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The 
LRINEC (Laboratory Risk Indicator for Necrotizing 
Fasciitis) score: A tool for distinguishing necrotizing 
fasciitis from other soft tissue infections. Crit Care Med. 
2004;32(7):1535–41. 
34. Abdullah M, McWilliams B, Khan SU. Reliability of the 
Laboratory Risk Indicator in Necrotising Fasciitis 
(LRINEC) score. Surgeon. 2019;17(5):309–18. 
35. Bechar J, Sepehripour S, Hardwicke J, Filobbos G. 
Laboratory risk indicator for necrotising fasciitis (LRINEC) 
score for the assessment of early necrotising fasciitis: A 
systematic review of the literature. Ann R Coll Surg Engl. 
2017;99(5):341–6. 
36. Foo RM, Tung ML CD. Necrotizing fasciitis in 
haemtological patients: Enterobacteriaceae 
predominance and limited utility of laboratory risk score 
indicator for necrotizing fasciitis score. open forum 
infecious Dis. 2015;2(2):1–4. 
28  
37. El-Menyar A, Asim M, Mudali IN, Mekkodathil A, Latifi R, 
Al-Thani H. The laboratory risk indicator for necrotizing 
fasciitis (LRINEC) scoring: The diagnostic and potential 
prognostic role. Scand J Trauma Resusc Emerg Med. 
2017;25(28):3–9. 
38. Su YC, Chen HW, Hong YC, Chen CT, Hsiao CT, Chen 
IC. Laboratory risk indicator for necrotizing fasciitis score 
and the outcomes. ANZ J Surg. 2008;78(11):968–72. 
39. Bozkurt O, Sen V, Demir O, Esen A. Evaluation of the utility of 
different scoring systems (FGSI, LRINEC and NLR) in the 
management of Fournier’s gangrene. Int Urol Nephrol. 
2015;47(2):243–8. 
40. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome 
Prediction in Patients with Fournier’s Gangrene. J Urol. 
1995;154(1):89–92. 
41. Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, 
Davies BJ. Validation of the Fournier’s Gangrene Severity 
Index in a Large Contemporary Series. J Urol. 
2008;180(3):944–8. 
42. Anaya DA. Predicting_death_in_necrotizin.PDF. Surg 
Infect (Larchmt). 2009;10(6):517–22. 
43. Kao LS, Lew DF, Arab SN, Todd SR, Awad SS, Carrick 
MM, et al. Local variations in the epidemiology, 
microbiology, and outcome of necrotizing soft-tissue 
infections: A multicenter study. Am J Surg. 
2011;202(2):139–45. 
44. Das DK, Baker MG, Venugopal K. Risk factors, 
microbiological findings and outcomes of necrotizing 
fasciitis in New Zealand: A retrospective chart review. 
BMC Infect Dis. 2012;12:6–10. 
45. Bjurlin MA, O’Grady T, Kim DY, Divakaruni N, Drago A, 
29  
Blumetti J, et al. Causative pathogens, antibiotic 
sensitivity, resistance patterns, and severity in a 
contemporary series of Fournier’s gangrene. Urology. 
2013;81(4):752–9. 
46. Stevens, Dennis L., Bryant Amy E. YS. Invasive group A 
streptococcal infection: new concepts in antibiotic 
treatment. Int J Antimicrob Agents. 1994;4:297–301. 
47. Wasserman S, Boyles T, Mendelson M. Pocket Guide To 
Antibiotic Prescribing for Adults in South Africa, 2015. 
South African Antibiot Steward Program. 2015;1–60. 
48. Stempak LM, Middleton CE, Navalkele B, Leasure JE. 
How the pathologist can help the surgeon collect better 
specimens for microbiology culture. Arch Pathol Lab Med. 
2020;144(1):29–33. 
49. Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, 
Catena F, et al. World Society of Emergency Surgery ( 
WSES ) guidelines for management of skin and soft tissue 
infections. 2014;1–18. 
50. Gelbard RB, Ferrada P, Dante Yeh D, Williams BH, Loor 
M, Yon J, et al. Optimal timing of initial debridement for 
necrotizing soft tissue infection: A Practice Management 
Guideline from the Eastern Association for the Surgery of 
Trauma. J Trauma Acute Care Surg. 2018;85(1):208–14. 
51. Cocanour CS, Chang P, Huston JM, Adams CA, Diaz JJ, 
Wessel CB, et al. Management and Novel Adjuncts of 
Necrotizing Soft Tissue Infections. Surg Infect (Larchmt). 
2017;18(3):250–72. 
52. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, 
Follin P, et al. Intravenous Immunoglobulin G Therapy in 
Streptococcal Toxic Shock Syndrome: A European 
Randomized, Double-Blind, Placebo-Controlled Trial. Clin 
Infect Dis. 2003;37(3):333–40. 
30  
53. Madsen MB, Hjortrup PB, Hansen MB, Lange T, Norrby- 
Teglund A, Hyldegaard O, et al. Immunoglobulin G for 
patients with necrotising soft tissue infection (INSTINCT): 
a randomised, blinded, placebo-controlled trial. Intensive 
Care Med. 2017;43(11):1585–93. 
54. Bulger EM, Maier R V., Sperry J, Joshi M, Henry S, Moore 
FA, et al. A novel drug for treatment of necrotizing soft- 




Publication ready manuscript 
 
Title: Describing the resistance patterns of necrotising fasciitis in Acute Care 
Surgery 
 
Authors: Dr Tumiso BM Mabogoane 
MBChB(Pret), FCS (SA) 
Department of Surgery 




Co-authors: Dr Shreya Rayamajhi 
MBChB (UFS), FCS (SA), MMed (UCT) 
Department of Surgery 
Groote Schuur Hospital, Cape town 
 
 
Dr Christo Kloppers 
MBChB (Stell), FCS(SA), MMed (UCT), MPhil (UCT) 
Department of Surgery 




Keywords: Necrotising fasciits, microbiology, resistance patterns 
 
 
Ethics reference: Human Research Ethics Committee of University of Cape 









Objective-- This study aims to identify the microorganisms and 
antibiotic resistance patterns in necrotising fasciitis. 
Methods This is a retrospective audit over two consecutive 
years(June 2015 - July 2017) of all patients who had surgery for 
necrotising fasciitis at the ACS unit in Cape Town. 
Results Necrotising fasciitis accounted for 15% of all skin and 
soft tissue sepsis that required surgery. There were ten male 
(52.6%) and nine female (47.4%) patients. The most common co 
- morbidity was diabetes mellitus in 10 (52.6%) patients, the 
compliance and control were monitored by glycosylated 
haemoglobin (HbA1C) in 50% of the diabetic group, with a mean 
of 8.98 (Range 5-12.9). Fifteen percent of cases (n=3) had a 
confirmed diagnosis of HIV, with a negative result in 8(42%). ICU 
was required in three patients two of whom were on inotropes 
and one patient required renal replacement therapy. Surgery 
was performed within 24 hours for 11 (57%) patients. The most 
common anatomical site for debridement was perineum in nine 
patients (47%). Monomicrobial infection was the most common 
subtype of necrotising fasciitis with methicillin sensitive 
staphylococcus aureus in 5 (26%) as the predominant microbe. 
Gram-negative organism Escherichia coli was the second most 
common monomicrobial infection. All Gram-positive organisms 
were sensitive to cloxacillin and co-amoxiclavulanic acid. Two 
gram negatives (15%) of the 13 organisms cultures were 
resistant to co-amoxiclavulanic acid. The 30 day mortality was 
15 %. 
Conclusion In our limited series monomicrobial infection is the 
most common subtype. 15% of the community acquired 





Introduction and background 
 
Necrotizing soft-tissue infections (NSTIs) are life-threatening, 
invasive often rapidly spreading soft-tissue infections which can 
involve any or all layers of the skin and soft-tissue compartment. 
It primarily involves the relatively avascular muscle fascia and 
can later cause secondary necrosis of surrounding 
subcutaneous fat and skin. Classically the appearance of tissue 
has been described by the friability of the tissue and loss of 
tissue planes which is associated with dish-water grey exudate 
with or without purulent collections.1 The incidence of NSTI in the 
western countries has been described as 0.4 per 100 000 
population and associated with mortality ranging from 30-80% 
depending on the subtype and immune status of the patient.2 The 
pathophysiology of NF involves a breach of the skin barrier 
protection or by haematogenous spread of the bacterium.1 
Immune suppression due to various chronic ailments e.g. 
diabetes mellitus has been associated with an increased 
predisposition for NF. In South Africa, we do not know the 
incidence or mortality of necrotising fasciitis. The underlying 
socioeconomics of a middle to low income country results in 
delayed access to health care, delayed diagnosis and delay to 
surgery. Immune suppression from poorly controlled diabetes or 
untreated HIV could impact outcomes. There is no data to 
support or refute these clinical impressions. There are sparse 
data on microbiology and antibiotic resistance to aid local 
antibiotic guidelines. 
 
The purpose of this study is to identify what is the microbiology 
and resistance patterns of necrotizing soft tissue infection the 








A retrospective review was performed of operative reports and 
theatre records to identify patients who had surgery for soft 
tissue infection in the Acute Care Surgery (ACS) unit at Groote 
Schuur Hospital for 24 months from 1 June 2015 to 31 July 2017. 
The inclusion criteria were patients above the age of 18 years 
presenting to the ACS unit who required surgery for necrotising 
fasciitis. The anatomical sites were the torso, abdomen, 
perineum and lower extremities. Excluded patients were 
paediatric patients (below 18 years), debridement that was 
performed at a referring institution, anatomical sites that are 
referred to other speciality and hence surgery not performed by 
ACS i.e. otolaryngology and orthopaedic surgery and all non- 
necrotising soft tissue sepsis. 
 
Data were retrieved from clinical notes, operation reports and 
National Health Laboratory Services (NHLS) database. Data 
collected included demographics (gender, age), time of 
admission and surgery, presence of diabetes and human 
immune deficiency virus (HIV), biochemical markers of 
compliance with a recent HbA1C, HIV viral load and CD4 count 
and use of antiretroviral therapy. Admission vital signs (blood 
pressure, pulse rate and temperature) was recorded. We 
checked and collected the NHLS database for the following 
tests: presentation white cell count, renal function, blood culture 
during that admission, and tissue cultures sent during surgery. 
Organ failure and mortality during the same admission was 
recorded. 
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Data was captured on an Excel spreadsheet on a password 
protected computer that was only available to the investigators. 
Data will be analysed using Mathematica version 11.3, Wolfram 
Research, Urbana, Illinois, USA. The descriptive statistics were 
computed using the Microsoft Excel software (2017). Mortality is 
calculated at discharge and confirmed on Clinicom, which is a 
hospital database of all the patients reviewed in the public health 
care system. 
 
The protocol was approved by the ethics committee at the 
University of Cape town (HREC ref 569/2018). 
 
The NF classification referred to is based on microbiology. The 
commonly used antibiotics are co-amoxiclavulanic acid, 
clindamycin and ciprofloxacin for community acquired NF. HIV 
testing is not mandatory for all patients unless requested by the 
patient or if there is clinical suspicion. Glycosylated haemoglobin 
(HbA1C) was also not routinely checked and was dependant on 
clinician decision. Diabetic foot sepsis and necrosis were 
excluded from this study inadvertently as it is seen as a different 






There were 120 operations performed for soft tissue sepsis from 
June 2015 to July 2017, at ACS Groote Schuur hospital. Simple 
abscess drainage was performed on 31 cases and 37 patients 
had a debridement for non- necrotising soft tissue sepsis. These 
patients were excluded from our study. A further 17 cases had 
to be excluded as enough data could not be retrieved from 







120 soft tissue sepsis surgery  
  
 Exclusion criteria 
  Abscess drainage 
(n=31) 
  Non-necrotising 
soft tissue infection 
(n=37) 
  Duplication (n=5) 
  Missing folder data 
(n= 7) 




 Multiple NF debridement 
(n=11)  









Of all soft tissue sepsis surgery performed in that time frame 
(n=120), 15.8% (n=19) had surgical confirmation of necrotising 
fasciitis with microbiology samples available for analysis in this 
study. There were nine females (47.4%) and ten males (52.6%). 
The mean age of the patients was 41 (SD 15.76). Ten (52.6%) 
patients were known with diabetes and three of those were 
insulin dependent. HbA1C was checked in 50% of the diabetic 
group and none of the non-diabetic group. The mean HbA1C 
was 8.98 (range 5-12.9) 
 
HIV ELISA was performed on ten patients, two were positive and 
eight negative. One patient was diagnosed previously and on 
anti-retroviral therapy. Seven patients were never tested for HIV. 
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The mean heart rate on admission was 99 beats per minute with 
42% (8) being tachycardic (HR>100) and mean systolic blood 
pressure was 126mmHg. Two patients presented in septic shock 
requiring ICU admission and inotrope support. The mean white 
cell count (WCC) was 22.3 cells/mL3. Acute kidney injury was 
found in five (26.3%) patients with one requiring renal 
replacement therapy while in intensive care. There were three 
ICU admissions. 
 
TABLE 1: DEMOGRAPHICS AND CLINICAL PARAMETERS 
  
 N % 
GENDER Male 10 52.6  
 Female 9 47.4  
RISK FACTORS Diabetes 10 52.6  
 HIV 3 15.7  
  
  Mean SD Range 
AGE Age (Years) 41.84 15.76 20-72 
VITAL SIGNS Heart rate (Beats / minute) 99.05 18.96 67-140 
 Systolic Blood pressure (mmHg) 126 27.96 70-180 
 Temperature (Degree Celsius) 37.4 0.78 36.4-39 
 White cell count (Cells/mL3) 22.38 10.44 4-49 
 Creatinine (mmol/L) 148 164.25 38-669 
SURGERY TIME Time to surgery (Hours) 11.74 12.63 1-48 
 
Surgery was performed within 24 hours in 11 (57.89%) of which 
seven was within six hours. Three patients (15.78%) waited 
longer than 24 hours although the mean time to surgery was 
11.74. For five patients the data could not be retrieved regarding 
waiting time to theatre. 
 
The anatomical area debrided was the perineum with nine 
patients (47.36%), then lower limb six (31.57%), and four torso 
(three anterior abdominal wall and one retroperitoneal). Re- 
debridement was deemed necessary on clinical grounds 
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indicated and performed for six patients with a further two 
requiring more than one relook. No patients had flaps or skin- 
graft and all healed with secondary intention. There were no 
amputations performed. 
 
Intra-operative specimen sent were as follows: nine tissue 
cultures and three pus swabs. The microscopy showed mixed 
flora in seven samples, however, more than one organism was 
identified only in three samples. There were five gram-positive 
organisms, three staphylococcus aureus, one Streptococcus 
anginosus (STRAN) and one Streptococcus constellatus subsp 
pharynges (STRCP). Three cultures identified a single 
bacterium. These were two pseudomonas (Putida and 
Aeruginosa) and one Enterobacter aerogenes. Three patients 
had a mixed growth of two or more gram-negative and anaerobic 
organisms (Escherichia coli, Providentia stuartii, Proteus 
mirabilis, Citrobacter freundii and Enterococcus faecium). None 
of the blood cultures taken on admission yielded any organism 
growth. 
 
The three Staphylococcus aureus organisms were all sensitive 
to cloxacillin, one was resistant to penicillin and one was 
resistant to penicillin, macrolides and clindamycin. The STRAN 
was a sensitive organism and STRCP was only resistant to 
macrolides. All three pseudomonas were sensitive to 
ciprofloxacin and cephalosporins. Two of the pseudomonas 
were resistant to trimethoprim. The two Escherichia coli were 
both resistant to ampicillin/amoxicillin but sensitive to co- 
amoxiclavulanic acid, cephalosporins and aminoglycosides. The 
enterobacter aerogenes was resistant to co-amoxyclavulanic 
acid, ampicillin, cefoxitin but sensitive to ciprofloxacin, cefepime 
and aminoglycosides. The enterobacter faecium was also a 
moderately resistant organism with resistance to ampicillin and 
aminoglycosides. The proteus mirabilis was a sensitive 
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organisms. The citrobacter freundii was a moderately resistant 
organism with resistance to ampicillin, co-amoxyclavulanic acid 
and cephalosporins. It was sensitive to carbapenems, 
ciprofloxacin, aminoglycosides and trimethoprim. Of the 13 
organisms cultured two (15.3) were resistant to the empiric 
antibiotic of choice co-amoxiclavulanic acid. All gram-positives 
were sensitive to cloxacillin and co-amoxiclavulanic acid. Two 
gram- negatives were resistant to co-amoxiclavulanic acid and all 






























TABLE 2: MICROBIOLOGY AND RESISTANCE 
 Organism Resistant antibiotics 
GRAM POSITIVE 
1 Staphylococcus Aureus Bactrim 
2 Staphylococcus Aureus Ampicillin 





4 Streptococcus Constalatus SP Erythromycin 
Azythromycin 






















In hospital mortality rate was 15.7%. All three ICU admissions 
died. The aetiology of NF in the mortality group was appendicitis 
with retroperitoneal sepsis, Fournier’s gangrene and abdominal 






The ACS unit serves a diverse community of middle to low 
income population in an urban and some under-developed 
communities. Community acquired resistance is not as prevalent 
as in first world countries like the USA where up to 26% of 
community staphylococcus sepsis is MRSA3. This is a small 
case series of NF, being retrospective data retrieval was poor. 
The total number of cases was significantly less than what we 
perceived our clinical load was. The diabetic foot necrosis and 
progressive sepsis were not included in this study. That 
contributed towards the decreased total number of cases and 
amputations performed. The ACS unit was also in its inception 
years and patient management had not been standardised. And 
yet there were a few learning points from this case series. 
 
The incidence of NF is increasing globally. This has been 
attributed to worldwide obesity and hence increasing numbers of 
patients with diabetes mellitus. There was a 35% cumulative 
increase between 2001 and 2010 with a 2.7% per year increase 
in a study from Texas.4 This is the largest cohort study on NF 
epidemiology trends in the literature. There are small case series 
over a period of time suggesting a global increase in incidence.5 
The incidence figures for many African and other middle to low 
income countries are lacking including South Africa. This study 
was not aimed or powered to work out the incidence in our 
community. However, we can estimate that the South African 
incidence of NF is on the rise together with the rise of obesity 
and diabetes. 
 
This series has reiterated that septic markers like temperature, 
heart rate and WCC are not always raised despite patients 
having frank necrosis. The risk prediction scores have failed to 
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be diagnostic for NF due to these variables not responding 
uniformly. NF remains a clinical diagnosis and requires a high 
index of suspicion. 
 
This disease process affected young diabetics most in our study 
(50% diabetic, mean age 41). This was similar to the systematic 
review by Marchesi which looked at 15 studies and found 
diabetes to be a risk factor in 60% of patients.6 Only half the 
diabetics had their glycaemic control checked with HbA1C with 
a mean above 8. Every contact with health care is an opportunity 
to check compliance, optimise medication and intervene should 
there be any warning signs. Since the time of data collection, the 
ACS in house diabetic protocol has changed and currently, we 
check HbA1Cs on all diabetics unless already done within 3 
months of admission. Our endocrinologists work closely and 
advise on optimisation. The dieticians and diabetic nurse will be 
involved as needed to aid the patient. 
 
The prevalence of HIV in South Africa is 20.4% and 12 % of the 
adults in Western Cape are infected with HIV.7 HIV was not a 
major risk factor associated with NF (15.7%) despite the 
increased prevalence of HIV in our communities. This also is in 
line with other surgical complications literature on HIV positive 
patients. In the emergency surgery setting, well controlled HIV 
infection does not increase morbidity and mortality.8,9 It is also 
surprising that with such high prevalence in the country, this 
hospital admission was not used as an opportunity to counsel 
the patient for an HIV test on all. The current practice in ACS has 
also changed. All admitted patients are counselled and if willing, 
a test is performed. HIV has become a chronic illness and many 
life-threatening complications of AIDS can be prevented by 
treatment. 
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Monomicrobial gram-positive NF was the most common like in 
other series, however, the causative organism here is 
staphylococcus aureus instead of streptococcal species10. The 
second prominent organism was Escherichia coli infection in 
isolation or polymicrobial infection. This infection was commonly 
seen in patients who have perianal sepsis. 
 
Community acquired methicillin resistant staphylococcus aureus 
was not present in any of our patients. This supports the empiric 
antibiotic protocol of omitting vancomycin. Currently, the 
institutional recommendations of covering gram-negative and 
gram-positive organisms and including the anaerobes are 
validated by our findings of the typical microbes found in NF.11 
The gram-negative organisms, however, showed some 
resistance to co- amoxiclavulanic acid. Two of the 13 organisms 
found in the first debridement specimen (15.3%) were resistant 
to co- amoxiclavulanic acids which are the empiric antibiotic of 
choice. This being a small case series is difficult to interpret to 
change management guidelines and policies. We need to do an 
adequately powered study to validate these results and thus use 
this as a pilot study. 
 
The extremities were seen to be frequently affected in 
international literature.12,13,10 However, in this series the 
perineum was more prominent. Due to the exclusion of diabetic 
foot sepsis and NF associated with that, this series is not a true 
reflection of all NF cases operated on. 
 
Forty percent(n=4) of the samples that were taken from the 
perineal location did not yield any results as some were rejected 
by the microbiology laboratory. These could be as a result of 
specimen incorrectly labelled, inadequate samples, or 
inappropriate preservation of tissue handed in for processing. All 
surgeons and registrars should be educated about the correct 
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sampling techniques and should be encouraged to send tissue 
for MCS for all patients with NSTIs. 
 
Timing of the debridement was primarily within 48 hours and 
when the index of suspicion was increased the debridement 
occurred within six hours of being seen. Though there is no 
“golden hour “on the timing of debridement in literature, the 
standard practice is to aim for debridement within 12 hours 
14. The delayed group did not contribute to patients who had poor 
outcomes in this series. Regardless NF is lethal and expedited 
surgery within 12 hours of admission should be the aim, source 
control is paramount. 
 
The mortality in our small case series was 15% (n=3), lower than 
reported in the literature. Of the three patients who succumbed 
to death, only one patient was infected with HIV and antiretroviral 
naïve. The other two were diabetic patients. All three deaths 
were on patients with organ failure requiring support and they 
had torso NF (appendicitis, abdominal wall and Fournier’s 
gangrene) These are predictors of poor outcome and the limited 






This is a small case series but has highlighted a few aspects of 
NF and patient management. It’s the basics we need to do right. 
For e.g. early diagnosis, expedited source control while obtaining 
adequate samples at debridement as it could alter treatment in 
15% and moving forward with better optimisation of chronic 
diseases. Patients with established organ failure are at high risk 
of mortality. An adequately powered prospective analysis of NF 
resistance patterns is necessary for our practice as this pilot 
study suggests that our empiric antibiotic of choice might not 




The management for the chronic comorbidity is physician 
dependent and thus not all the variables are equal, recording of 
past medical history. A protocol has since been devised to 
equate for some of the same variables i.e. diabetics on 
medication need to be followed for compliance to medication 
evidenced by HBA1C. The incidence of HIV in surgical 
emergencies is not known if the test is not readily done or 
recorded as part of co morbidities. Now in keeping with the WHO 
guidelines, when a patient is newly diagnosed regardless of the 
CD4, antiretrovirals are initiated. That suggests that the records 








The incidence of obesity in our population but has not previously 
been accounted for when describing debridement of soft tissue 
infections. In the era of antiretroviral therapy, HIV is becoming 
more of a well-controlled comorbid disease. The evidence is 
needed relating to incidence and outcomes related to emergency 
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